Gelonhui, March 22, 丨 Kunming Pharmaceutical Group (600422.SH) announced that in order to meet operating and development needs and expand corresponding financing channels, the company and its subsidiaries plan to apply for a financing amount not exceeding RMB 2,616 million from financial institutions in 2023. The final amount is subject to the amount actually approved by each financial institution.
昆药集团(600422.SH)：2023年度拟向金融机构申请融资额度不超26.16亿元
Kunming Pharmaceutical Group (600422.SH): The amount of financing to be applied to financial institutions in 2023 will not exceed 2,616 billion yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.